GT Biopharma, Inc. (GTBP) Financials

GTBP Assets vs Liabilities

DateAssetsLiabilities
2023-09-30 16.1 million 6.1 million
2023-06-30 18.1 million 6.4 million
2023-03-31 20.1 million 7.0 million
2022-12-31 16.7 million 5.0 million

GTBP Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-09-30 -2.0 million 862000
2023-06-30 -1.9 million 259000
2023-03-31 -2.9 million 646000
2022-12-31 -4.3 million 1.3 million

GTBP Net Income

No data available :(

GTBP Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-09-30 16.0 million - 92000
2023-06-30 18.0 million - 120000
2023-03-31 19.9 million - 147000
2022-12-31 16.5 million - 174000

GTBP Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-09-30 41.0 million
2023-06-30 40.2 million
2023-03-31 39.1 million
2022-12-31 31.9 million

GTBP Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-09-30 - 1.4 million 1.8 million -
2023-06-30 - 2.1 million 1.5 million -
2023-03-31 - 1.7 million 2.0 million -
2022-12-31 - 2.8 million 1.9 million 1.1 million

GTBP Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-09-30 - -
2023-06-30 - -
2023-03-31 - -
2022-12-31 - -

GTBP

Price: $3.06

52 week price:
3.06
16.11

Earnings Per Share: -5.58 USD

P/E Ratio: -0.54

Exchange: NCM

Sector: Healthcare

Industry: Biotechnology

Volume: 64789

Market Capitalization: 5.4 million

Links: